EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

Author:

Schwab Claire1,Ryan Sarra L.1,Chilton Lucy1ORCID,Elliott Alannah1,Murray James1,Richardson Stacey1,Wragg Christopher2,Moppett John3,Cummins Michelle3,Tunstall Oliver3,Parker Catriona A.4,Saha Vaskar45,Goulden Nicholas6,Vora Ajay7,Moorman Anthony V.1,Harrison Christine J.1

Affiliation:

1. Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom;

2. Bristol Genetics Laboratory, Southmead Hospital, North Bristol National Health Service Trust, Bristol, United Kingdom;

3. Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom;

4. Children’s Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, United Kingdom;

5. Department of Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India;

6. Department of Haematology, Great Ormond Street Hospital, London, United Kingdom; and

7. Department of Haematology, Sheffield Children’s Hospital, Sheffield, United Kingdom

Abstract

Key Points EBF1-PDGFRB fusion accounts for ∼0.5% of B-cell precursor acute lymphoblastic leukemia and 2.7% of the B-other subtype. EBF1-PDGFRB-positive patients are MRD positive and are slow early responders who respond to imatinib.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3